Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-216210
Filing Date
2018-07-11
Accepted
2018-07-11 17:30:37
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-1/A d521849ds1a.htm S-1/A 2526691
2 EX-1.1 d521849dex11.htm EX-1.1 189326
3 EX-3.3 d521849dex33.htm EX-3.3 84384
4 EX-5.1 d521849dex51.htm EX-5.1 9992
5 EX-23.1 d521849dex231.htm EX-23.1 1388
6 GRAPHIC g521849dsp47.jpg GRAPHIC 2677
7 GRAPHIC g521849g14h50.jpg GRAPHIC 144801
8 GRAPHIC g521849g25i47.jpg GRAPHIC 98910
9 GRAPHIC g521849g32e47.jpg GRAPHIC 48399
10 GRAPHIC g521849g40c11.jpg GRAPHIC 92084
11 GRAPHIC g521849g41w64.jpg GRAPHIC 89429
12 GRAPHIC g521849g48n25.jpg GRAPHIC 55355
13 GRAPHIC g521849g51q40.jpg GRAPHIC 50531
14 GRAPHIC g521849g65v09.jpg GRAPHIC 191612
15 GRAPHIC g521849g78m75.jpg GRAPHIC 86180
16 GRAPHIC g521849g81r65.jpg GRAPHIC 69059
17 GRAPHIC g521849g86o64.jpg GRAPHIC 115236
18 GRAPHIC g521849g92g41.jpg GRAPHIC 72197
  Complete submission text file 0001193125-18-216210.txt   4352087
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-226093 | Film No.: 18949280
SIC: 2834 Pharmaceutical Preparations